11,011 Shares in Bath & Body Works, Inc. (NYSE:BBWI) Acquired by Keybank National Association OH

Keybank National Association OH bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,011 shares of the company’s stock, valued at approximately $427,000.

Several other institutional investors have also recently added to or reduced their stakes in BBWI. Golden State Wealth Management LLC purchased a new stake in Bath & Body Works during the fourth quarter worth approximately $26,000. SRS Capital Advisors Inc. lifted its stake in Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after buying an additional 329 shares during the last quarter. True Wealth Design LLC lifted its stake in Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after buying an additional 1,054 shares during the last quarter. UMB Bank n.a. lifted its stake in Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after buying an additional 335 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new stake in Bath & Body Works in the third quarter valued at approximately $39,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of BBWI stock opened at $32.66 on Monday. The business’s fifty day moving average price is $37.25 and its 200 day moving average price is $34.17. Bath & Body Works, Inc. has a 1-year low of $26.20 and a 1-year high of $52.99. The firm has a market capitalization of $7.07 billion, a PE ratio of 7.97, a P/E/G ratio of 0.92 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Equities research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.45%. The ex-dividend date was Friday, February 21st. Bath & Body Works’s dividend payout ratio (DPR) is 21.98%.

Bath & Body Works announced that its board has authorized a stock buyback plan on Thursday, February 27th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 6.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s board believes its shares are undervalued.

Analyst Ratings Changes

A number of brokerages have weighed in on BBWI. Morgan Stanley reduced their price objective on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. TD Cowen boosted their price objective on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Raymond James reiterated an “outperform” rating and issued a $46.00 price objective (up previously from $42.00) on shares of Bath & Body Works in a research note on Tuesday, February 25th. Telsey Advisory Group reiterated an “outperform” rating and issued a $43.00 price objective on shares of Bath & Body Works in a research note on Thursday, February 27th. Finally, JPMorgan Chase & Co. set a $47.00 price target on Bath & Body Works in a research note on Thursday, February 27th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $45.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.